Latest News
House of Representatives Passes 21st Century Cures
The House of Representatives has passed 21st Century Cures. Cure SMA is proud to support this legislation. Thank you for your calls and tweets to voice your support to your […]
Read More ›Seven Individuals and Families Recognized for Their Contributions to the Community
Each year, while much of our community is gathered together, we use the Annual SMA Conference to recognize several individuals, families and foundations who have provided special support to the […]
Read More ›Cytokinetics Releases Update on Phase 1 Trial at Annual SMA Conference
At last week’s Annual SMA Conference, Cytokinetics released additional data from their Phase 1 study of CK-2127107, a skeletal muscle activator. Cytokinetics, in partnership with Astellas, has already announced that […]
Read More ›Isis Announces Additional Trial Results at Annual SMA Conference
At last week’s Annual SMA Conference, Isis Pharmaceuticals, Inc. provided an update on children with spinal muscular atrophy (SMA) who have completed the open-label, Phase 2 multiple-dose study of ISIS-SMNRx […]
Read More ›Cure SMA Announces Nearly $2 Million in New Planned Research Funding
Cure SMA has announced plans to fund $1.995 million in new research grants over the next several months. This includes funding for all four areas of our research model—basic research, […]
Read More ›Dr. Mary Schroth Joins Cure SMA as Medical Professional Education Consultant
We are very excited to announce that Dr. Mary Schroth has joined us as our medical professional education consultant. She will be working with us a few days each month, […]
Read More ›